Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 49 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


11.		Phase II Immunotherapy with IFN-beta-ser for Favorable Prognosis Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								AECM-8508188 NCI-V86-0030


12.		Phase II Immunotherapy with Human Fibroblast Interferon for Metastatic or Recurrent Soft Tissue Sarcomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								ICC-81M1 NCI-V83-0226


13.		Phase II Interferon-B Immunotherapy for Recurrent Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				21 to 75								YALE-HIC-2830 NCI-V83-0022


14.		Phase II Immunotherapy with Beta (Fibroblast) Interferon for Recurrent Disseminated Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								FHCRC-151 NCI-V83-0105


15.		Phase II Immunotherapy with IFN-b-ser in Patients with Recurrent and/or Metastatic Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								OSP-8503 NCI-V85-0084


16.		Phase II Immunotherapy with Intravenous IFN-b-ser in Patients with Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								UMCC-8501 NCI-V85-0080


17.		Phase II Immunotherapy with Recombinant Beta Interferon in Patients with Measurable Hairy Cell Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								AECM-TB01-23485 NCI-V85-0225


18.		Phase II Immunotherapy with IFN-beta-ser in Patients with Measurable Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								OSP-8504 NCI-V85-0255


19.		Phase II Immunotherapy with Recombinant Beta Interferon in Patients with Diffuse Malignant Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-8526 SWOG-8526

Last Modified: 1/1/1989


20.		Phase II Master Protocol for the Evaluation of New Treatments in Patients with Primary Liver Cancer --- IFN-beta(ser) and Menogaril (Summary Last Modified 01/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				any age				NCI				EST-1286 EST-1286

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute